Therefore, specific modulators of the TRAIL signaling axis and vitamin D analogs may lead to the development of randomized clinical trials to rescue from the consequences of vitamin D deficiency in both mother and infant. The gene discussed is TNFSF10; the disease is vitamin D deficiency.